SCHEMBL5794201

SCHEMBL5794201

COc1cc2c(-c3ccc[nH]3)cn(C)c2cc1OCCO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.49
CDK2 P24941 3/20 0.40
TUBB1 Q9H4B7 1/20 0.36
RET P07949 3/20 0.36
GSK3B P49841 4/20 0.35
PRKCA P17252 1/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
AURKB Q96GD4 4/20 0.34
JAK2 O60674 1/20 0.34
LCK P06239 1/20 0.34
GSK3A P49840 1/20 0.34
CDK7 P50613 1/20 0.34
BTK Q06187 1/20 0.34
LRRK2 Q5S007 1/20 0.34
AURKA O14965 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5794891 0.90 IGF1R (0.50) IGF1RCDK2RETGSK3BPRKCA
SCHEMBL5793291 0.88 IGF1R (0.56) IGF1RCDK2RETGSK3BPRKCA
SCHEMBL5798073 0.84 IGF1R (0.45) IGF1RRETAURKAKDRFLT4
SCHEMBL5796367 0.83 BRD4 (0.45) IGF1RKDRFLT4
SCHEMBL5818753 0.80 IGF1R (0.47) IGF1RCDK2GSK3BPRKCAMAPT
SCHEMBL1748786 0.79 IGF1R (0.83) IGF1RCDK2RETGSK3BAURKB
SCHEMBL5794484 0.77 IGF1R (0.40) IGF1RGSK3BMEN1ALDH1A1MAPT
SCHEMBL5794829 0.73 IGF1R (0.39) IGF1RCDK2GSK3BMEN1ALDH1A1
SCHEMBL5070003 0.72 GSK3B (0.56) IGF1RRETGSK3BPRKCAMEN1
SCHEMBL5795129 0.70 GSK3B (0.42) IGF1RCDK2GSK3BKDRFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732546-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS Aventis Pharma S.A. (FR) 2006-12-20 EP disclosed
WO-2005095399-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2005-10-13 WO disclosed